News

Researchers at Weill Cornell Medicine have demonstrated how amyloid beta, a peptide associated with Alzheimer’s disease, can interact with a protein receptor on immune cells in the brain triggering a reaction that damages blood vessels and leads to neurodegeneration. 

Researchers at Weill Cornell Medicine have led a phase 1 trial of a new drug that delivers potent radiation therapy directly and specifically to cancer cells in patients with advanced prostate cancer. The clinical trial showed that the “radiopharmaceutical” was well tolerated and demonstrated promising antitumor activity.

A surprising mechanism that makes some cancers treatment-resistant has been discovered by Weill Cornell Medicine and NewYork-Presbyterian investigators.

The Department of Emergency Medicine has made tremendous strides since 2018, when Weill Cornell Medicine elevated it to a full academic department, an achievement that underscores the department’s mission to provide exceptional patient care.

Awards, honors and achievements for the month of October.  

The institution is expanding its real estate agreement at 575 Lexington Ave. to provide state-of-the-art clinical care at the Midtown Manhattan location by 2025.

Ambulance-based mobile stroke units (MSU) can reach patients faster to deliver clost-busting drugs that increase the likelihood of averting strokes and complete recovery compared with standard hospital emergency care, according to researchers at Weill Cornell Medicine, NewYork-Presbyterian, UTHealth Houston, Memorial Hermann-Texas Medical Center and five other medical centers across the United States.

Dr. Maya Hogg, a leading hospitalist, has been appointed chief of medicine at NewYork-Presbyterian Lower Manhattan Hospital and vice chair in the Weill Department of Medicine at Weill Cornell Medicine.

Certain gut-dwelling fungi flourish in severe cases of COVID-19, amplifying the excessive inflammation that drives this disease while also causing long-lasting changes in the immune system, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.

Estrogen-based menopause hormone therapy for women in mid-life should be investigated more thoroughly as a potential strategy for preventing Alzheimer’s disease, the most common form of dementia, according to a new analysis from researchers at Weill Cornell Medicine.

Mental health crises among children and adolescents requiring emergency department care skyrocketed during the pandemic and have stayed elevated despite a return to normalcy, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators.

Dr. Gulkarov was also recruited to Weill Cornell Medicine as an associate professor of clinical cardiothoracic surgery.

In experiments of unprecedented scale, investigators at Weill Cornell Medicine and the National Institutes of Health have revealed new aspects of the complex genetics behind Type 2 diabetes.

The institution is constructing a modern new student residence that, when it opens in 2025, will expand the scope of the institution’s Upper East Side campus and nearly double the existing student residential living space.

For the sixth consecutive year, Weill Cornell Medicine has been awarded the Health Professions Higher Education Excellence in Diversity (HEED) Award by INSIGHT Into Diversity magazine, which recognizes the institution’s exceptional commitment to diversity and inclusion.

An American Heart Association (AHA) Presidential Advisory, co-authored by a committee including the dean of Weill Cornell Medicine, outlines an ambitious plan to increase rigorous research on initiatives aimed at providing food as medicine for chronic conditions.

Weill Cornell Medicine has been at the forefront of medical education since its inception, with a steadfast commitment to providing the best training for generations of physicians.

Dr. Lisa Newman, chief of the...

A Weill Cornell Medicine researcher has received a $610,000 grant from the Department of Defense to investigate the mechanisms causing DNA instability that potentially drives metastasis in bladder cancer.

Dr. Chenxu Zhu, an assistant professor of physiology and biophysics at Weill Cornell Medicine and a core faculty member of the New York Genome Center, has been awarded the National Institutes of Health Director’s New Innovator Award to fund an ambitious project to develop single-cell sequencing tools, known collectively as “multi-omics,” that will help track age-related changes in gene regulation programs, as well as cell decay, in brain cells from preclinical models.